Literature DB >> 16391413

Exogenous melatonin delays gastric emptying rate in rats: role of CCK2 and 5-HT3 receptors.

O Kasimay1, B Cakir, E Devseren, B C Yegen.   

Abstract

Pineal hormone melatonin is proposed as a potential treatment for severe sleep disturbances, and various gastrointestinal disorders. It was shown that melatonin increases intestinal motility and influences the activity of myoelectric complexes of the gut. The aim of the study was to evaluate the mechanisms of the effect of exogenous melatonin on gastric emptying rate. Male Sprague-Dawley rats were fitted with gastric cannulas under anesthesia. The rate of gastric emptying of saline was determined after instillation into the gastric fistula, from the volume and phenol red concentrations recovered after 5 min. Melatonin injected intraperitoneally (ip; 0.001-100 mg/kg) delayed gastric emptying rate of saline at 3 and 10 mg/kg doses. When administered ip 15 min before melatonin (10 mg/kg) injections, CCK2 (L-365,260, 1 mg/kg) or 5-HT3 receptor (ramosetrone, 50 microg/kg) blockers abolished melatonin-induced delay in gastric emptying rate, while the blockade of sympathetic ganglia (bretylium tosylate, 15 mg/kg) significantly reduced the delay in gastric emptying rate. CCK1 receptor blocker (L-364,718, 1 mg/kg) had no significant effect on the delaying action of melatonin. Our results indicate that pharmacological doses of melatonin delay gastric emptying via mechanisms that involve CCK2 and 5-HT3 receptors. Moreover, it appears that exogenous melatonin inhibits gastric motility in part by activating sympathetic neurons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16391413

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  9 in total

1.  Non-sulfated cholecystokinin-8 increases enteric and hindbrain Fos-like immunoreactivity in male Sprague Dawley rats.

Authors:  Amged I Dafalla; Thaer R Mhalhal; Kenneth Hiscocks; John Heath; Ayman I Sayegh
Journal:  Brain Res       Date:  2018-12-17       Impact factor: 3.252

2.  Characterization of signaling pathways coupled to melatonin receptors in gastrointestinal smooth muscle.

Authors:  Rashad Ahmed; Sunila Mahavadi; Othman Al-Shboul; Sayak Bhattacharya; John R Grider; Karnam S Murthy
Journal:  Regul Pept       Date:  2013-03-27

3.  Secretion of melatonin and 6-sulfatoxymelatonin urinary excretion in functional dyspepsia.

Authors:  Cezary Chojnacki; Tomasz Poplawski; Grażyna Klupinska; Janusz Blasiak; Jan Chojnacki; Russel J Reiter
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

Review 4.  Distribution, function and physiological role of melatonin in the lower gut.

Authors:  Chun-Qiu Chen; Jakub Fichna; Mohammad Bashashati; Yong-Yu Li; Martin Storr
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

5.  Melatonin and peripheral circuitries: insights on appetite and metabolism in Danio rerio.

Authors:  Chiara Carla Piccinetti; Beatrice Migliarini; Ike Olivotto; Marco Pasquale Simoniello; Elisabetta Giorgini; Oliana Carnevali
Journal:  Zebrafish       Date:  2013-05-19       Impact factor: 1.985

6.  The effects of melatonin on colonic transit time in normal controls and IBS patients.

Authors:  Wei-Zhen Lu; Guang-Hui Song; Kok-Ann Gwee; Khek-Yu Ho
Journal:  Dig Dis Sci       Date:  2008-08-23       Impact factor: 3.199

Review 7.  Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms.

Authors:  Michael Camilleri
Journal:  J Physiol       Date:  2014-03-24       Impact factor: 5.182

Review 8.  Circadian dysrhythmia-linked diabetes mellitus: Examining melatonin's roles in prophylaxis and management.

Authors:  Adejoke Y Onaolapo; Olakunle J Onaolapo
Journal:  World J Diabetes       Date:  2018-07-15

9.  Effects of 5-HT receptor antagonists on cisplatin-induced kidney injury.

Authors:  Mitsuhiro Goda; Masaya Kanda; Toshihiko Yoshioka; Ami Yoshida; Yoichi Murai; Yoshito Zamami; Fuka Aizawa; Takahiro Niimura; Hirofumi Hamano; Naoto Okada; Kenta Yagi; Masayuki Chuma; Yuki Izawa-Ishizawa; Keisuke Ishizawa
Journal:  Clin Transl Sci       Date:  2021-06-02       Impact factor: 4.689

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.